Explore the latest in urology, including recent advances in treatment of UTIs, incontinence, and prostate and bladder cancers.
This study examines prostate-specific antigen values among transgender women in the Veterans Health Administration receiving estrogen.
This cohort study compares the stage and grade of prostate cancer at diagnosis among Black men compared with men of other races and ethnicities.
This cohort study seeks to develop a linkage between a prostate genomic classifier and clinical data across payers and sites of care in the US to evaluate relevant disease outcomes, including prostate cancer biology and clinical management.
This cohort study evaluates whether receipt of androgen deprivation therapy is associated with outcomes among Black men with prostate cancer who underwent radiation therapy.
This JAMA Internal Medicine Patient Page describes urinary tract infections, their causes, and how to treat them and prevent future episodes.
This Clinical Insights discusses special considerations in recurrent urinary tract infection diagnosis and management in older women.
This systematic review and meta-analysis investigates the incidence of cardiovascular events with addition of novel androgen receptor signaling inhibitors (ARSI) to standard of care in locally advanced and metastatic prostate cancer.
This cohort study evaluates associations of county-level prostate-specific antigen (PSA) screening prevalence with prostate cancer outcomes, including mortality, as well as variation by sociodemographic and clinical factors.
This cohort study examines whether a watchful waiting treatment strategy is associated with adverse outcomes in men with nonmetastatic prostate cancer and a life expectancy of less than 10 years in Sweden.
This prospective, multicenter cohort study evaluates the long-term outcomes of men diagnosed with favorable-risk prostate cancer managed with protocol-directed active surveillance, including regular biopsies and prostate-specific antigen screening, from 2008 to 2022.
This cohort study aims to determine the risk of hypertension in normotensive adults who donated a kidney compared with nondonors of similar baseline health.
This randomized clinical trial evaluates whether a multilevel advance care planning (ACP) intervention improves clinician ACP documentation for patients with advanced genitourinary cancers compared with a clinician-level intervention only.
This review assesses current evidence and emerging treatment strategies for improved survival among patients with metastatic hormone-sensitive prostate cancer and offers recommendations for clinical practice application.
This nonrandomized clinical trial evaluates the efficacy and safety of a tailored approach with nivolumab plus ipilimumab as an immunotherapeutic boost in patients with metastatic urothelial carcinoma.
Customize your JAMA Network experience by selecting one or more topics from the list below.